Tissue-selective effects of continuous release of 2-hydroxyestrone and 16α-hydroxyestrone on bone, uterus and mammary gland in ovariectomized growing rats

Journal of Endocrinology

Volumn 170, Issue 1, 2001, Pages 165-174

  Lotinun, S ^a   Westerlind, K C ^a   Turner, R T ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

16ALPHA HYDROXYESTRONE; 2 HYDROXYESTRONE; ANTIESTROGEN; CELL NUCLEUS ANTIGEN; CHOLESTEROL; ESTRADIOL; ESTRONE; FULVESTRANT; PLACEBO; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE; BONE ATROPHY; BONE GROWTH; BONE MINERALIZATION; BONE TURNOVER; BREAST CANCER; CANCELLOUS BONE; CELL LABELING; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CORTICAL BONE; DOSE RESPONSE; DRUG ACTIVITY; DRUG IMPLANT; DRUG PELLET; EPIPHYSIS; EPITHELIUM CELL; ESTROGEN METABOLISM; FEMALE; GROWTH; HORMONE ACTION; HORMONE RELEASE; HYDROXYLATION; MEASUREMENT; METABOLITE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; RISK FACTOR; TARGET ORGAN; TIBIA; TISSUE SPECIFICITY; UDDER; UTERUS; UTERUS WEIGHT; WEIGHT GAIN;

ANIMALS; BONE REMODELING; CHOLESTEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG IMPLANTS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; HYDROXYESTRONES; MAMMARY GLANDS, ANIMAL; MODELS, ANIMAL; ORGAN SIZE; OVARIECTOMY; PROLIFERATING CELL NUCLEAR ANTIGEN; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; UTERUS;

EID: 0034913405     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1700165     Document Type: Article

References (38)

1. Estrogen-induced uterine responses and growth: Relationship to receptor estrogen binding by uterine nuclei
2. Catecholestrogens (2- and 4-hydroxyestrogens): Chemistry, biogenesis, metabolism, occurrence and physiological significance
3. Raloxifene (LY139481 HCl) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats
4. Estradiol 16α-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: A possible model for the hormonal etiology of breast cancer in humans
5. 16α-Hydroxylation of estradiol : A possible risk marker for breast cancer
6. Black-white differences in serum sex hormones and bone mineral density
7. The effects of orbital spaceflight on bone histomorphometry and messenger ribonucleic acid levels for bone matrix proteins and skeletal signaling peptides in ovariectomized growing rats
8. Metabolism of exogenous 4- and 2-hydroxyestradiol in human male
9. Tissue-selective actions of estrogen analogs
10. Estrogens and breast cancer
11. Biological properties of 16α-hydroxyestrone: Implications in estrogen physiology and pathophysiology
12. Estrogenic and antiestrogenic activities of 16α- and 2-hydroxy metabolites of 17β-estradiol in MCF-7 and T47D human breast cancer cells
13. Cyclical gestagen (MPA) supplement for continuous transdermal or oral estrogen substitution in postmenopause: Modification of serum lipids
14. Increased inactive estrogen metabolites in urine of early postmenopausal women with low bone density
15. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats
16. Dietary ethanol does not accelerate bone loss in ovariectomized rats
17. The oxidative metabolism of estradiol conditions postmenopausal bone density and bone loss
18. Metabolic clearance of catechol estrogens
19. Catechol estrogens and estrogen receptors
20. P450 enzymes of estrogen metabolism
21. Direct action of naturally occurring estrogen metabolites on human osteoblastic cells
22. Abnormal oxidative metabolism of estradiol in women with breast cancer
23. Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells
24. Evidence that ibuprofen antagonizes selective actions of estrogen and tamoxifen on rat bone
25. Influence of development, estrogens and food intake on apolipoproteins AI, AII and E mRNA in rat liver and intestine
26. Covalent binding of the endogenous estrogen 16α-hydroxyestrone to estradiol receptor in human breast cancer cells: Characterization and intranuclear localization
27. Ethnic differences in estrogen metabolism in healthy women
28. The effects of ovariectomy and 17 beta-estradiol on cortical bone histomorphometry in growing rats
29. Tamoxifen prevents the skeletal effects of ovarian hormone deficiency in rats
30. Skeletal effects of estrogen
31. Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptor from human breast cancers
32. Opposite effects of estrogen and catecholestrogen on hormone-sensitive breast cancer cell growth and differentiation
33. The hormonal activity of the postmenopausal ovary
34. The effect of long-term ovarian hormone deficiency on transforming growth factor-beta and bone matrix protein mRNA expression in rat femora
35. Estrogen regulates the rate of bone turnover but bone balance in ovariectomized rats is modulated by prevailing mechanical strain
36. Differential effects of estrogen metabolites on bone and reproductive tissues of ovariectomized rats
37. Skeletal alterations in ovariectomized rats
38. Temporal relationship between bone loss and increased bone turnover in ovariectomized rats